Peter Riedell to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Peter Riedell has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.175
-
Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results. Blood Adv. 2023 06 13; 7(11):2283-2286.
Score: 0.145
-
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic. Biol Blood Marrow Transplant. 2020 07; 26(7):1239-1246.
Score: 0.029